These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26169436)

  • 1. Cost-Effectiveness Analysis of a National Newborn Screening Program for Biotinidase Deficiency.
    Vallejo-Torres L; Castilla I; Couce ML; Pérez-Cerdá C; Martín-Hernández E; Pineda M; Campistol J; Arrospide A; Morris S; Serrano-Aguilar P
    Pediatrics; 2015 Aug; 136(2):e424-32. PubMed ID: 26169436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of tandem mass spectrometry screening in California.
    Feuchtbaum L; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S280-6. PubMed ID: 16735254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
    Cipriano LE; Rupar CA; Zaric GS
    Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive cost-utility analysis of newborn screening strategies.
    Carroll AE; Downs SM
    Pediatrics; 2006 May; 117(5 Pt 2):S287-95. PubMed ID: 16735255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program.
    Barbosa C; Smith EA; Hoerger TJ; Fenlon N; Schillie SF; Bradley C; Murphy TV
    Pediatrics; 2014 Feb; 133(2):243-53. PubMed ID: 24394684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel.
    Insinga RP; Laessig RH; Hoffman GL
    J Pediatr; 2002 Oct; 141(4):524-31. PubMed ID: 12378192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness Methods and Newborn Screening Assessment.
    Castilla-Rodríguez I; Vallejo-Torres L; Couce ML; Valcárcel-Nazco C; Mar J; Serrano-Aguilar P
    Adv Exp Med Biol; 2017; 1031():267-281. PubMed ID: 29214578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Incidence of Partial Biotinidase Deficiency in the First 3 Years of a Regional Newborn Screening Program in Italy.
    Semeraro D; Verrocchio S; Di Dalmazi G; Rossi C; Pieragostino D; Cicalini I; Ferrante R; Di Michele S; Stuppia L; Rizzo C; Lepri FR; Novelli A; Dionisi-Vici C; De Laurenzi V; Bucci I
    Int J Environ Res Public Health; 2022 Jul; 19(13):. PubMed ID: 35805799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of expanded newborn screening in Texas.
    Tiwana SK; Rascati KL; Park H
    Value Health; 2012; 15(5):613-21. PubMed ID: 22867769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system.
    Moreno S; González J; Lekander I; Martí B; Oyagüez I; Sánchez-de la Rosa R; Casado MA
    Clin Ther; 2010 Dec; 32(13):2232-45. PubMed ID: 21316539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State.
    Ding Y; Thompson JD; Kobrynski L; Ojodu J; Zarbalian G; Grosse SD
    J Pediatr; 2016 May; 172():127-35. PubMed ID: 26876279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL; Willis WD; Foos V
    Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of newborn screening for severe combined immunodeficiency.
    Van der Ploeg CPB; Blom M; Bredius RGM; van der Burg M; Schielen PCJI; Verkerk PH; Van den Akker-van Marle ME
    Eur J Pediatr; 2019 May; 178(5):721-729. PubMed ID: 30805731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola.
    McGann PT; Grosse SD; Santos B; de Oliveira V; Bernardino L; Kassebaum NJ; Ware RE; Airewele GE
    J Pediatr; 2015 Dec; 167(6):1314-9. PubMed ID: 26477868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness analysis of universal screening for thyroid disease in pregnant women in Spain].
    Donnay Candil S; Balsa Barro JA; Álvarez Hernández J; Crespo Palomo C; Pérez-Alcántara F; Polanco Sánchez C
    Endocrinol Nutr; 2015; 62(7):322-30. PubMed ID: 25977144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and cost-effectiveness of universal screening for hearing loss in newborns.
    Kezirian EJ; White KR; Yueh B; Sullivan SD
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):359-67. PubMed ID: 11283492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Background and Disease Prevalence of Biotinidase Deficiency in a Polish Population-Data Based on the National Newborn Screening Programme.
    Jezela-Stanek A; Suchoń L; Sobczyńska-Tomaszewska A; Czerska K; Kuśmierska K; Taybert J; Ołtarzewski M; Sykut-Cegielska J
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 700 patients referred with a preliminary diagnosis of biotinidase deficiency by the national newborn metabolic screening program: a single-center experience.
    Erdol S; Kocak TA; Bilgin H
    J Pediatr Endocrinol Metab; 2023 Jun; 36(6):555-560. PubMed ID: 37119528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.